ArticleFrontiers in endocrinology2026

Systematic monitoring identified a high incidence of hypopituitarism following combined ipilimumab plus nivolumab therapy for metastatic melanoma.

Mahir Hasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.